PALISADE BIO, INC.: 10-Q filed 2014-11-07
What PALISADE BIO, INC. reported in its quarterly report filed 2014-11-07 (fiscal Q3 2014): 25 published measures, 70 facts as tagged in accession 0001144204-14-065859.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-11-07
- Fiscal period
- fiscal Q3 2014
- Accession
- 0001144204-14-065859 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PALISADE BIO, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 29,443,295 | USD | |
| At 2013-12-31 | 19,413,536 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 8,539,308 | USD | |
| At 2013-12-31 | 10,995,337 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 20,903,987 | USD | |
| At 2013-12-31 | 8,418,199 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 11,945,253 | USD | |
| At 2013-12-31 | 16,846,052 | USD | |
| At 2013-09-30 | 16,401,728 | USD | |
| At 2012-12-31 | 7,443,773 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | -4,455,237 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -17,125,576 | USD | 273 |
| 2013-07-01 to 2013-09-30 | -6,686,957 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -16,528,674 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 172,171 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 118,938 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 5,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 14,167 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 2,500 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 107,500 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | -145,551,613 | USD | |
| At 2013-12-31 | -128,426,037 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 301,282 | USD | |
| At 2013-12-31 | 230,971 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 656,947 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 3,638,972 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 1,007,453 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 2,080,740 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | -4,106,745 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -12,794,884 | USD | 273 |
| 2013-07-01 to 2013-09-30 | -3,633,986 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -9,761,368 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 27,734,384 | USD | |
| At 2013-12-31 | 17,619,119 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 361,619 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 1,191,976 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 448,943 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 936,471 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 5,704,917 | USD | |
| At 2013-12-31 | 5,936,132 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 32,761 | USD | |
| At 2013-12-31 | 10,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 4,111,745 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 12,809,051 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 3,636,486 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 9,868,868 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 2,058,865 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 5,577,644 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 1,847,403 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 5,502,137 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 87,155,672 | shares | |
| At 2013-12-31 | 77,886,031 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 165,577,933 | USD | |
| At 2013-12-31 | 136,058,135 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 6,110 | USD | |
| At 2013-12-31 | 7,241 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 1,245,502 | USD | |
| At 2013-12-31 | 1,137,701 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-09-30 | 57,720 | USD | |
| At 2013-12-31 | 64,897 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | 1,969,879 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 6,971,186 | USD | 273 |
| 2013-07-01 to 2013-09-30 | 1,707,690 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 4,184,740 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-07-01 to 2014-09-30 | -348,492 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -4,330,692 | USD | 273 |
| 2013-07-01 to 2013-09-30 | -3,052,971 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -6,767,306 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-09-30 | 22,761 | USD | 273 |
| 2013-01-01 to 2013-09-30 | 4,167 | USD | 273 |
Inspect the source
- Entity
- PALISADE BIO, INC. / CIK 0001357459
- Captured
- 2026-09-20T07:55:46.162Z
- SEC response SHA-256
1d4973c07aed8ad894103731546b55683b331acdd472b37e4b33a98a2f63a74c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001357459.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))